Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
Clinical trial NCT06279741 · RECRUITING
Trial details
- NCT number
- NCT06279741
- Sponsor
- EXO Biologics S.A.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2027-01-31
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.